Cinque, A.; Capasso, A.; Vago, R.; Lee, M.W.; Floris, M.; Trevisani, F.
The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now? Biomedicines 2022, 10, 90.
https://doi.org/10.3390/biomedicines10010090
AMA Style
Cinque A, Capasso A, Vago R, Lee MW, Floris M, Trevisani F.
The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now? Biomedicines. 2022; 10(1):90.
https://doi.org/10.3390/biomedicines10010090
Chicago/Turabian Style
Cinque, Alessandra, Anna Capasso, Riccardo Vago, Michael W Lee, Matteo Floris, and Francesco Trevisani.
2022. "The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now?" Biomedicines 10, no. 1: 90.
https://doi.org/10.3390/biomedicines10010090
APA Style
Cinque, A., Capasso, A., Vago, R., Lee, M. W., Floris, M., & Trevisani, F.
(2022). The Role of Circulating Biomarkers in the Oncological Management of Metastatic Renal Cell Carcinoma: Where Do We Stand Now? Biomedicines, 10(1), 90.
https://doi.org/10.3390/biomedicines10010090